How to Build Investor Confidence in Microbiome Drug Development: Workshop Insights  Â
Introduction: The Expert Line-up The recent Microbiome Drug Development Searchlight workshop was hosted by industry luminaries such as Sonia Timberlake from Timberlake & MacIsaac Biopharma Consulting, and Caleb Bell & Sou Miyake from Corundum Systems Biology. Their combined expertise provided attendees with a deep dive into the strategies needed to foster investor confidence in…Read more
Read MoreExploring the Depths of the Human Intestinal EnvironmentÂ
Profiling the human intestinal environment under physiological conditions Dari Shalon, Rebecca Neal Culver, Jessica A. Grembi, and their esteemed team have pioneered research that explores the intricate realm of the human intestinal environment. Their comprehensive study addresses previous limitations in understanding the intestinal microbiome.  Revolutionizing Gut Sampling Techniques   Traditionally, sampling the human…Read more
Read MoreFecal Microbiota Transplantation in Advanced Melanoma Treatment: An Insight
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial In their groundbreaking paper, Bertrand Routy, John G. Lenehan, and team explore the potential of Fecal Microbiota Transplantation (FMT) in enhancing the efficacy of immune checkpoint inhibitors for refractory melanoma patients. By combining FMT with PD-1 inhibitors, they provide insights into first-line…Read more
Read MoreVaginal Microbiota Transplant (VMT): A Step Forward in Treating Vaginal Dysbiosis
Antibiotic-free vaginal microbiota transplant with donor engraftment, dysbiosis resolution and live birth after recurrent pregnancy loss: In an innovative study, Tine Wrønding, Kilian Vomstein, and collaborators delve into the transformative potential of Vaginal Microbiota Transplantation (VMT) for addressing vaginal dysbiosis without traditional antibiotics. Their groundbreaking research reveals new hope for patients experiencing recurrent pregnancy loss.…Read more
Read More